Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis

Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis

JULY 2006 | Kurt Degenhardt, Robin Mathew, Brian Beaudoin, Kevin Bray, Diana Anderson, Guanghua Chen, Chandreyee Mukherjee, Yufang Shi, Céline Gélinas, Yongjun Fan, Deirdre A. Nelson, Shengkan Jin, and Eileen White
The study investigates the role of autophagy in tumor cell survival and its impact on necrosis, inflammation, and tumorigenesis. It demonstrates that defective apoptosis in immortalized epithelial cells leads to increased tumorigenicity, and this is further exacerbated by inhibiting autophagy through AKT activation or beclin1 disruption. Under conditions of metabolic stress, cells that lack apoptosis can survive through autophagy, but when both apoptosis and autophagy are impaired, necrotic cell death occurs. This necrosis is associated with inflammation and accelerated tumor growth. The study also shows that autophagy is localized to hypoxic regions of tumors before angiogenesis, and that beclin1 haploinsufficiency impairs autophagy and promotes tumorigenesis. Additionally, oncogene-activated necrosis in tumors stimulates an inflammatory response, which may impact tumor growth. The findings suggest that autophagy may function in tumor suppression by mitigating metabolic stress and preventing necrosis, while necrosis can be a regulated process interdependent on apoptosis and autophagy.The study investigates the role of autophagy in tumor cell survival and its impact on necrosis, inflammation, and tumorigenesis. It demonstrates that defective apoptosis in immortalized epithelial cells leads to increased tumorigenicity, and this is further exacerbated by inhibiting autophagy through AKT activation or beclin1 disruption. Under conditions of metabolic stress, cells that lack apoptosis can survive through autophagy, but when both apoptosis and autophagy are impaired, necrotic cell death occurs. This necrosis is associated with inflammation and accelerated tumor growth. The study also shows that autophagy is localized to hypoxic regions of tumors before angiogenesis, and that beclin1 haploinsufficiency impairs autophagy and promotes tumorigenesis. Additionally, oncogene-activated necrosis in tumors stimulates an inflammatory response, which may impact tumor growth. The findings suggest that autophagy may function in tumor suppression by mitigating metabolic stress and preventing necrosis, while necrosis can be a regulated process interdependent on apoptosis and autophagy.
Reach us at info@study.space